Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Rovelt

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Acta Ophthalmologica|March 7, 2026
The impacts of high refractive errors on self-reported visual function and visual concernJens Riis Møller, Arevak Saruhanian, Jens Rovelt, et al.
Frontiers in Neuroscience|March 10, 2022
Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, et al.
International Journal of Molecular Sciences|January 11, 2024
Distinct Metabolic Profiles of Ocular Hypertensives in Response to HypoxiaMia Langbøl, Jens Rovelt, Arevak Saruhanian, et al.
Cellular and Molecular Neurobiology|October 4, 2024
Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Cellular and Molecular Neurobiology|August 16, 2024
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Acta Ophthalmologica|March 7, 2026
The impacts of high refractive errors on self-reported visual function and visual concernJens Riis Møller, Arevak Saruhanian, Jens Rovelt, et al.
Frontiers in Neuroscience|March 10, 2022
Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, et al.
International Journal of Molecular Sciences|January 11, 2024
Distinct Metabolic Profiles of Ocular Hypertensives in Response to HypoxiaMia Langbøl, Jens Rovelt, Arevak Saruhanian, et al.
Cellular and Molecular Neurobiology|October 4, 2024
Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Cellular and Molecular Neurobiology|August 16, 2024
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Pageof 2